Oncimmune Holdings PLC (AIM:ONC)'s Adam Hill talks to Proactive London's Katie Pilbeam about their latest results as their US-driven momentum continues with a number of ImmunoINSIGHTS clients more than doubling year-on-year.
Hill also talks about the details of signing a commercial collaboration deal with a health company owned by Google’s parent, Alphabet - Verily Life Sciences to assess long Covid data.
The teams will use autoantibody profiling of patients to see if the markers present early in the infection are associated with persistent symptoms and after-effects and remain present after the initial illness.